Nevada’s Oversight of Opioid-Affected Infant Care Under Scrutiny
A recent legislative audit has raised concerns over the Nevada government’s management of care plans for infants impacted by opioid exposure, pointing to significant oversight failures.
Healthcare providers in Nevada are mandated to develop comprehensive plans for infants experiencing opioid-related conditions, ensuring both the infant and their mother or caregiver receive appropriate care. The Nevada Division of Public and Behavioral Health (DPBH) bears the responsibility of overseeing and monitoring the execution of these plans.
However, the audit revealed that DPBH did not fulfill its monitoring duties effectively. Analysis of 20 care plans showed that 20% lacked documented services or referrals for the affected infants. Furthermore, 45% failed to record whether treatment referrals were offered to the mothers. Additionally, the audit found no evidence that the DPBH had evaluated or tracked the implementation of these care plans.
These oversight issues could have serious implications, potentially affecting the well-being of infants and threatening federal funding aimed at opioid prevention if regulations are not met. Despite the audit being released in April, the administration under Governor Joe Lombardo has yet to announce corrective measures or updates regarding these deficiencies.
In 2022, Nevada registered approximately 1,056 drug overdose fatalities, as per the Centers for Disease Control and Prevention (CDC). The state has shown minimal improvement in reducing overdose deaths compared to broader national trends, which have been declining.
As Governor Lombardo seeks re-election, his administration’s handling of this issue may become a focal point. His opponent, Attorney General Aaron Ford, has played a crucial role in securing $1.2 billion from opioid settlements for the state.
For more details, please visit the original article on American Journal News.
